Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED)
Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED)
Jens Meier, Günther Krumpl, Kurt Krejcy, Charu Kohli et al.
Citations
4 citations
Journal
EP Europace
Topics
Cardiac Arrhythmias and Treatments
Field-Weighted Citation Impact (FWCI)
5.55
article
Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED)
Jens Meier, Günther Krumpl, Kurt Krejcy, Charu Kohli, Matthias Mai, Jakob Ackerl, Brigitte Stiller, Martin Unger, László Környei, Ferran Rosés‐Noguer, Ina Michel‐Behnke, Thomas Kriebel, Seymour I. Schlager, Christoph Klade, Matthias Müller, Roman Gebauer, Majed Kanaan
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
EP EuropaceVol. 27(2)
Institutions
Hebron University (PS), Universitat Autònoma de Barcelona (ES), University of Freiburg (DE), Universitätsklinikum Gießen und Marburg (DE), Vienna General Hospital (AT), Harefield Hospital (GB), Gottsegen National Cardiovascular Center (HU), Westpfalz Klinikum (DE), Olgahospital (DE), AOP Orphan (Austria) (AT), Leipzig Heart Institute (DE), Kepler Universitätsklinikum (AT), Vall d'Hebron Hospital Universitari (ES), World Rugby (IE), ERN GUARD-Heart (NL), Medical University of Vienna (AT), RWTH Aachen University (DE)